The North America anti-viral therapies market is expected to reach US$ 31,092.80 million by 2027 from US$ 16,312.45 million in 2019; it is estimated to grow at a CAGR of 8.5% from 2020 to 2027.
Increasing R&D expenditures in pharmaceutical companies and rising government support for research activities and clinical trials are the key factors driving the growth of the anti-viral therapies market in the region. However, the high cost of drug development is the major factor hindering the market growth.
Antiviral therapy is one of the most exciting branches of virology. These therapies are based on several strategies—direct-acting antivirals target viral proteins, enzymes, or nucleic acids; passive antibodies neutralize circulating viruses; and several other antivirals target cellular proteins or processes essential for viral replication.
Increasing prevalence of chronic viral infectious diseases, such as hepatitis, AIDS, and viral influenza; and emergence and re-emergence of new viral infections, such as diseases caused by coronavirus and picornaviruses, have boosted the demand for novel antiviral therapeutic strategies. The molecular mechanism of viral infection is a field with huge potential for the development of new antiviral drugs or agents that target viral proteins or host factors. The antiviral therapies or agents are used stand-alone or in combination with other drugs to control the viral diseases. Earlier, in the clinical trials, a drug combo already used against HIV in. In addition, during the World War II, a malaria treatment first tested, and in 2019, a new antiviral launched that promise against Ebola fizzled. Further, in 2020, Gilead Sciences initiated two Phase-3 studies of investigational antiviral Remdesivir for the treatment of COVID-19.
North America has been witnessing growing number of COVID-19 cases since its outbreak. In the US, the FDA has approved the emergency-use authorization of experimental drugs. Clinical trials of Remdesivir, monoclonal antibodies, interferons, ACE inhibitors, and hydroxychloroquine have all been registered in the US. Further, American pharmaceutical companies are taking tremendous efforts to develop drugs and vaccines for the COVID-infected patients. AbbVie, Harbour BioMed (HBM), Utrecht University (UU), and Erasmus Medical Center (EMC) have collaborated to develop a novel therapeutic antibody to prevent and treat COVID-19. Thus, the rising incidence of COVID-19 is escalating the demand for antiviral drugs in North America.
Mexico Anti-Viral Therapies Market, Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICAANTI-VIRAL THERAPIES MARKET SEGMENTATION
By Type
- Branded Drugs
- Generic Drugs
By Mechanism of Action
- Nucleotide Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Others
By Application
- HIV
- Hepatitis
- Virus Influenza
- Herpes
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- Abbott
- AbbVie Inc.
- Bristol-Myers Squibb Company
- Johnson and Johnson Services, Inc
- Merck & Co., Inc
- Gilead Sciences, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Mechanism of Action, and Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Anti-viral therapies Market – By Type
1.3.2 North America Anti-Viral Therapies Market – By Mechanism of Action
1.3.3 North America Anti-Viral Therapies Market– By Application
1.3.4 North America Anti-Viral Therapies Market – By Country
2. North America Anti-Viral Therapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Anti-Viral Therapies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anti-Viral Therapies Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Anti-Viral Therapies Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing R&D Expenditures in Pharmaceutical Companies
5.1.2 Rising Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
5.2.1 High Cost of Drug Development
5.3 Market Opportunities
5.3.1 Strong Pipeline of Anti-Viral Drugs
5.4 Future Trends
5.4.1 Growing Emphasis on Launching Anti-Viral Agents
5.5 Impact analysis
6. Anti-Viral Therapies Market – North America Analysis
6.1 North America Anti-Viral Therapies Market Revenue Forecasts and Analysis
7. North America Anti-Viral Therapies Market Analysis and Forecasts To 2027 – By Type
7.1 Overview
7.2 North America Anti-Viral Therapies Market, By Type 2019 & 2027 (%)
7.2.1 North America Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 Generic Drugs
7.3.1 Overview
7.3.2 North America Generic Drugs Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Branded Drugs
7.4.1 Overview
7.4.1.1 North America Branded Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Anti-Viral Therapies Market Analysis – By Mechanism of Action
8.1 Overview
8.2 North America Anti-Viral Therapies Market, By Mechanism of Action 2019-2027 (%)
8.2.1 North America Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Mechanism of Action (US$ Mn)
8.3 Nucleotide Polymerase Inhibitor
8.3.1 Overview
8.3.2 North America Nucleotide Polymerase Inhibitor Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Reverse Transcriptase Inhibitors
8.4.1 Overview
8.4.2 North America Reverse Transcriptase Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Protease Inhibitors
8.5.1 Overview
8.5.2 North America Protease Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Anti-Viral Therapies Market Analysis and Forecasts To 2027 – By Application
9.1 Overview
9.2 North America Anti-Viral Therapies Market, By Application 2019 & 2027 (%)
9.2.1 North America Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 HIV
9.3.1 Overview
9.3.2 North America HIV Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Hepatitis
9.4.1 Overview
9.4.2 North America Hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Herpes
9.5.1 Overview
9.5.2 North America Herpes Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Influenza
9.6.1 Overview
9.6.2 North America Influenza Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Other Applications
9.7.1 Overview
9.7.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Anti-Viral Therapies Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Anti-Viral Therapies Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.4 North America: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.5 North America: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.6 North America: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
10.1.7 US: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.7.3 US: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.7.4 US: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.8 Canada: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.8.3 Canada: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.8.4 Canada: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.9 Mexico: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.9.3 Mexico: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.9.4 Mexico: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Anti-viral therapies Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Abbott
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AbbVie Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bristol-Myers Squibb Company
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Johnson and Johnson Services, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck & Co., Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Gilead Sciences, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by Major Pharmaceutical Companies
Table 2. North America Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 3. North America Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Mechanism of Action (US$ Mn)
Table 4. North America Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 5. North America Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. North America Anti-Viral Therapies Market, by Mechanism of Action – Revenue and Forecast to 2027 (USD Million)
Table 7. North America Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 8. US Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. US Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 10. US Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 13. Canada Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 17. Glossary of Terms, Anti-Viral Therapies Market
LIST OF FIGURES
Figure 1. Anti-viral therapies Market Segmentation
Figure 2. North America Anti-Viral Therapies Market Overview
Figure 3. Branded Drugs Segment Held Largest Share of Anti-Viral Therapies Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Anti-Viral Therapies Market - Leading Country Markets (US$ Mn)
Figure 6. Anti-Viral Therapies Market - North America PEST Analysis
Figure 7. Anti-Viral Therapies Market Impact Analysis of Driver and Restraints
Figure 8. North America Anti-viral therapies Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Anti-Viral Therapies Market, By Type 2019 & 2027 (%)
Figure 10. North America Generic Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Branded Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Anti-Viral Therapies Market, by Mechanism of Action 2019 & 2027 (%)
Figure 13. North America Nucleotide Polymerase Inhibitor Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Reverse Transcriptase Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Protease Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Anti-Viral Therapies Market, By Application 2019 & 2027 (%)
Figure 18. North America HIV Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Herpes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Influenza Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America: Anti-Viral Therapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 24. North America Anti-Viral Therapies Market Revenue and Forecast to 2027 (USD Million)
Figure 25. North America: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
Figure 26. US: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Canada: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Mexico: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in North American Country Markets
The List of Companies - North America Anti-Viral Therapies Market
- Abbott
- AbbVie Inc.
- Bristol-Myers Squibb Company
- Johnson and Johnson Services, Inc
- Merck & Co., Inc
- Gilead Sciences, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Anti-Viral Therapies Market
Sep 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Sep 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Sep 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)